RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
-4.89%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$1.16B
AUM Growth
+$1.16B
(-7.7%)
Cap. Flow
+$8.48M
Cap. Flow
% of AUM
0.73%
Top 10 Holdings %
Top 10 Hldgs %
55.45%
Holding
63
New
12
Increased
17
Reduced
17
Closed
13
Top Buys
| 1 |
Xencor
XNCR
|
$26.2M |
| 2 |
Penumbra
PEN
|
$23.4M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
$23.3M |
| 4 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$21.1M |
| 5 |
Puma Biotechnology
PBYI
|
$19.3M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$39.3M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$23.3M |
| 3 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$20.8M |
| 4 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$20.1M |
| 5 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$19.1M |
Sector Composition
| 1 | Healthcare | 95.37% |
| 2 | Financials | 0.92% |
| 3 | Communication Services | 0.62% |
| 4 | Consumer Staples | 0.41% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PTHN
26
DELISTED
Patheon N.V.
PTHN
| $12.7M | 1.09% |
+440,720
| New | +$12.7M |
|
|
SYRS
27
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $11.5M | 0.99% |
948,440
+55,658
| +6% | +$677K |
|
28
Elevance Health
ELV
$72.4B
| $11.1M | 0.96% |
+77,223
| New | +$11.1M |
|
29
eHealth
EHTH
$123M
| $10.6M | 0.92% |
+997,621
| New | +$10.6M |
|
30
Boston Scientific
BSX
$158B
| $9.94M | 0.86% |
459,505
-613,133
| -57% | -$13.3M |
|
|
NVTA
31
DELISTED
Invitae Corporation
NVTA
| $8.46M | 0.73% |
1,065,002
+554,633
| +109% | +$4.4M |
|
32
ProQR Therapeutics
PRQR
$255M
| $7.73M | 0.67% |
1,578,174
+1,002,311
| +174% | +$4.91M |
|
33
CytomX Therapeutics
CTMX
$343M
| $7.66M | 0.66% |
696,992
-17,700
| -2% | -$195K |
|
|
MODN
34
DELISTED
MODEL N, INC.
MODN
| $7.17M | 0.62% |
809,914
-741,045
| -48% | -$6.56M |
|
|
ELGX
35
DELISTED
Endologix Inc
ELGX
| $6.9M | 0.6% |
1,206,894
-2,273,750
| -65% | -$13M |
|
36
iRhythm Technologies
IRTC
$5.61B
| $6.86M | 0.59% |
+228,800
| New | +$6.86M |
|
|
WOOF
37
DELISTED
VCA Inc.
WOOF
| $4.81M | 0.41% |
70,040
-20,960
| -23% | -$1.44M |
|
|
SPNC
38
DELISTED
Spectranetics Corp
SPNC
| $4.6M | 0.4% |
187,627
-147,114
| -44% | -$3.6M |
|
|
GBT
39
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $4.57M | 0.39% |
+316,400
| New | +$4.57M |
|
40
Dynavax Technologies
DVAX
$1.18B
| $4.15M | 0.36% |
+1,049,791
| New | +$4.15M |
|
41
Fate Therapeutics
FATE
$115M
| $3.56M | 0.31% |
1,419,058
-6,100
| -0.4% | -$15.3K |
|
|
RARX
42
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $2.74M | 0.24% |
+180,310
| New | +$2.74M |
|
43
Aclaris Therapeutics
ACRS
$219M
| $2.56M | 0.22% |
+94,200
| New | +$2.56M |
|
|
DPLO
44
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $1.93M | 0.17% |
+153,317
| New | +$1.93M |
|
45
iShares Biotechnology ETF
IBB
$5.67B
| $1.19M | 0.1% |
+4,500
| New | +$1.19M |
|
46
UnitedHealth
UNH
$277B
| $291K | 0.03% |
1,820
| – | – |
|
47
Aurinia Pharmaceuticals
AUPH
$1.57B
| $77K | 0.01% |
36,743
-150,867
| -80% | -$316K |
|
48
Adverum Biotechnologies
ADVM
$66.5M
| $64K | 0.01% |
22,236
| – | – |
|
|
CSLT
49
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $51K | ﹤0.01% |
10,229
| – | – |
|
50
AstraZeneca
AZN
$253B
| – | – |
-288,356
| Closed | -$9.48M |
|